Neurocrine Biosciences, Inc.

NASDAQ:NBIX

119.85 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Assets:
Current Assets:
Cash & Cash Equivalents 251.1262.9340.8801112.279141.714254.71283.26774.19531.01444.78963.75450.10754.05137.32968.46799.66480.98149.94861.027105.85444.313163.88821.07821.311.715.811.3
Short Term Investments 780.5726.4370.5613.9558.245509.199261.217224.083304.996162.795100.95109.25978.99672.81416.13512.00679.721101.623223.12240.102347.314200.397156.094143.59269.8000
Cash and Short Term Investments 1,031.6989.3711.3801670.5650.913515.929307.35379.191193.809145.739173.013129.103126.86553.46480.473179.385182.604273.068301.129453.168244.71319.982164.6791.111.715.811.3
Net Receivables 439.3350185.5157.1126.57556.2431.1270000.02314.0891.9034.4700.0390.0277.1910.8588.21313.6590.2479.9495.9741.51.40.21.3
Inventory 38.335.130.52817.28810.864-31.127000-0.023-14.0890000000000000000
Other Current Assets 97.8464.2261.5215.2160.586.86438.993.0924.8834.3942.72316.2511.471.7161.9230.9113.5363.8635.3844.4734.9823.1371.5841.7612.252.560.459.5
Total Current Assets 1,6071,453.5972.81,016.2831737.777554.919310.442384.074198.203148.462189.264132.476133.05155.38781.423182.948193.658279.31313.815471.809248.094331.515172.40594.865.676.472.1
Non-Current Assets:
Property, Plant & Equipment, Net 347.3145.6155.8127.4116.233.86910.8116.2713.4322.5071.7711.91.5861.5322.6956.19182.59891.37899.307102.16656.23614.10212.08811.311.210.98.83.5
Goodwill 5.85.400000000000000000000000000
Intangible Assets 35.537.2000000000018.4023.400000000.1880.3620.611.21.4
Goodwill and Intangible Assets 35.537.2000000000018.4023.400000000.1880.3620.611.21.4
Long Term Investments 849.4401.5624.4265.3355.6216.028247.36143.4982.48837.49200.48-343.73.7396.41121.057000000000000
Tax Assets 362.6305.9315.1319.400000000325.3061.90000000000000
Other Non-Current Assets 49.6254.46.43.25.4774.54.8834.7914.8314.4434.3354.3066.102-78.9759.51111.108104.641104.506103.23626.914.3432.5591.8952.635.51
Total Non-Current Assets 1,644.4915.21,099.7718.5475255.374262.67254.64490.71144.836.2146.7155.89211.37315.43136.75993.706196.019203.813205.40283.14618.44514.83513.55714.414.915.55.9
Total Assets 3,251.42,368.72,072.51,734.71,306993.151817.591365.086474.785243.033154.676195.979138.368144.42470.818118.182276.654389.677483.123519.217554.955266.539346.35185.962109.280.591.978
Liabilities & Equity:
Current Liabilities:
Account Payables 108.976.351.539.446.21413.8015.6485.0852.5610.2460.1010.9111.1110.812.1881.5993.7763.2133.4475.3911.2951.9591.5391.0652.42.51.80.8
Short Term Debt 170.1169.416.510.3408.862.34538.37214.86212.4950011.2278.4518.6034.28910.9051.4864.4895.8146.6743.962.6582.0871.58710.80.90.8
Tax Payables 24.4900000000000000000000000000
Deferred Revenue 339.90-16.5-10.3-46.21410.23110.23110.23110.231002.91937.28439.9792.9412.9362.92806.53727.67449.6665.6995.38200000
Other Current Liabilities 35.9292194.3147.1156.51.8560.1750.2360.42815.41811.5980.5890.2643.38510.54310.65421.71712.41417.89519.84655.09122.16315.75312.3075.22.34.72.5
Total Current Liabilities 654.8537.7245.8186.5565.388.23354.42630.41425.71515.66411.69915.64647.1152.77719.96126.09429.90720.11633.69359.585110.01232.47924.76114.9598.65.67.44.1
Non-Current Liabilities:
Long Term Debt 258.393.5440.4412.386.7388.496369.61800000007.2410108.74549.15253.5959.45232.4735.2773.62.2832.12.20.70.8
Deferred Revenue Non-Current -78.6-32.800010.23110.23110.23110.23100026.92464.2089.66311.67614.59500218.2410.833000000
Deferred Tax Liabilities Non-Current 78.632.8000-10.231-10.23100000000.50-123.3400-2-18.241-0.833000000
Other Non-Current Liabilities 106.329.712.39.717.135.65721.4099.56414.38518.6722.56725.9614.2538.09429.49943.638128.055.6935.7366.35321.354.5297.5965.5122.10.70.60.3
Total Non-Current Liabilities 364.6123.2452.7422103.8424.153391.02719.79524.61618.6722.56725.96131.17772.30246.90355.314128.0554.84559.32665.80553.8239.80611.1967.7954.22.91.31.1
Total Liabilities 1,019.4660.9698.5608.5669.1512.386445.45350.20950.33134.33434.26641.60778.287125.07966.86481.408157.95774.96193.019125.39163.83542.28535.95722.75412.88.58.75.2
Equity:
Preferred Stock 0000000000000000000000000000
Common Stock 0.10.10.10.10.0920.0910.0890.0870.0860.0760.0670.0660.0550.0550.0440.0390.0380.0380.0370.0370.0350.0310.030.0250000
Retained Earnings -157.1-406.8-635.8-725.4-1,132.7-1,177.755-1,198.866-1,056.324-915.234-826.305-765.763-719.673-724.698-762.269-754.301-703.263-614.65-407.351-300.146-277.955-232.182-201.926-107.39-70.48-41.7-24.9-4.9-10
Accumulated Other Comprehensive Income/Loss 7-7.9-1.71.81.413-1.932-1.85-0.318-0.977-0.2770.005-0.002-0.087-0.0481.209-1.57-0.2330.099-1.504-2.2890.7412.065-2.2650.098-0.6-4.2-3-2
Other Total Stockholders Equity 2,3822,122.42,011.41,849.71,768.0951,660.3611,572.7651,371.4321,340.5791,035.205886.101873.981784.811781.607757.002741.568733.542721.93691.717674.034622.526424.084420.018233.565138.7101.191.184.8
Total Shareholders Equity 2,2321,707.81,3741,126.2636.9480.765372.138314.877424.454208.699120.41154.37260.08119.3453.95436.774118.697314.716390.104393.827391.12224.254310.393163.20896.47283.272.8
Total Equity 2,2321,707.81,3741,126.2636.9480.765372.138314.877424.454208.699120.41154.37260.08119.3453.95436.774118.697314.716390.104393.827391.12224.254310.393163.20896.47283.272.8
Total Liabilities & Shareholders Equity 3,251.42,368.72,072.51,734.71,306993.151817.591365.086474.785243.033154.676195.979138.368144.42470.818118.182276.654389.677483.123519.217554.955266.539346.35185.962109.280.591.978